GGrantIndex
Sort

46,585 grants matching heart failure

Pragmatic Randomized Trial of Calcitriol in Patients with Chronic Kidney Disease

$562,787
Delia Scholes · Kaiser Foundation Health Plan Of Washington · UH2 · FY2014 · HL

A novel approach to delivering therapeutics in heart transplantation

$562,730
Reza Abdi · Brigham And Women'S Hospital · R01 · FY2022 · HL

Project 3: Perception of Tobacco Use in Vulnerable Populations

$562,726
Herman Alfred Taylor · American Heart Association · P50 · FY2017 · HL

Improving Cardiac Rehabilitation outcomes through mobile case management (iCARE)

$562,687
Thomas Patrick Olson · Mayo Clinic Rochester · R01 · FY2023 · NR

Proteomics of Cardiovascular Risk: The Multiethnic Study of Atherosclerosis

$562,664
Peter Ganz · University Of California, San Francisco · R01 · FY2023 · HL

Project 1: Understanding normal tissue toxicity to identify patients most likely to benefit from proton therapy.

$562,644
Harald Paganetti · Massachusetts General Hospital · P01 · FY2023 · CA

Pediatric Cardiomyopathy Specimen Repository

$562,612
Jeffrey A Towbin · Cincinnati Childrens Hosp Med Ctr · R01 · FY2009 · HL

Peripheral Mechanisms of Cardiopulmonary Control during Exercise

$562,585
Thomas Patrick Olson · Mayo Clinic Rochester · R01 · FY2019 · HL

Signaling Mechanisms Governing Myocardial Fibrosis in Diseased Heart

$562,534
Hind Lal · University Of Alabama At Birmingham · R01 · FY2024 · HL

In vivo Imaging and Quantification of Cilia Beating Dynamics Using Phase-Resolved Optical Imaging Technology

$562,509
Zhongping Chen · University Of California-Irvine · R01 · FY2024 · EB

Impact of Medicare Part D Coverage Gap Closure on Health Outcomes

$562,495
Cameron Maxwell Kaplan · University Of Tennessee Health Sci Ctr · R01 · FY2017 · AG

Exosome-based therapeutics for heart failure

$562,482
Eduardo Marban · Cedars-Sinai Medical Center · R01 · FY2021 · HL

Understanding the role of bilevel positive airway pressure (BPAP) in pediatric acute asthma exacerbations: A prospective, randomized, double blind, controlled trial.

$562,440
Patrick Thomas Wilson · University Of Colorado Denver · R33 · FY2024 · HL

Early Prediction of Spontaneous Patent Ductus Arteriosus (PDA) Closure and PDA-Associated Outcomes

$562,405
Jonathan Lee Slaughter · Research Inst Nationwide Children'S Hosp · R01 · FY2023 · HL

Epigenetic signaling, pathological cardiac hypertrophy and Western diet

$562,332
Jiang Chang · Texas A&M University Health Science Ctr · R01 · FY2021 · HL

Reducing risk of Anthracycline-related heart failure after childhood cancer

$562,287
Saro Armenian · Beckman Research Institute/City Of Hope · R01 · FY2019 · CA

STK25 phosphorylates PRKAR1A to regulate PKA signaling

$562,257
Barry M. Fine · Columbia University Health Sciences · R01 · FY2023 · HL

Pharmacological Validation of Vascular KATP Channels for Modulating Ductus Arteriosus Tone

$562,249
Jerod S Denton · Vanderbilt University Medical Center · R01 · FY2021 · HD

ALTERED PPARx SIGNALING IN THE ISCHEMIC DIABETIC HEART

$562,112
Daniel Patrick Kelly · Washington University · P50 · FY2007 · HL

Brain ERK1/2 Signaling and Sympathetic Excitation in Heart Failure

$562,094
Robert B Felder · University Of Iowa · R01 · FY2019 · HL

Brain ERK1/2 Signaling and Sympathetic Excitation in Heart Failure

$562,094
Robert B Felder · University Of Iowa · R01 · FY2018 · HL

Regulation of myocardial GPCRs by USP20 in normal and hypertrophied heart

$562,065
Sudha K Shenoy · Duke University · R01 · FY2022 · HL

Regulation of myocardial GPCRs by USP20 in normal and hypertrophied heart

$562,065
Sudha K Shenoy · Duke University · R01 · FY2021 · HL

Regulation of myocardial GPCRs by USP20 in normal and hypertrophied heart

$562,065
Sudha K Shenoy · Duke University · R01 · FY2023 · HL

An expandable polymeric valved conduit to repair congenital heart disease

$562,061
David Kalfa · Columbia University Health Sciences · R01 · FY2022 · HL